Kemira Investor Presentation

CURRENT PORTFOLIO We already have a significant number of biobased products in our portfolio REVENUE SPLIT BY TYPE IN 2022 Biobased (>50%) Partly Biobased BIOBASED REVENUE DEVELOPMENT Revenue growth since 2020 coming from existing products, sizing in particular. 2022 revenue growth price-driven. Does not contain fossil-fuel based carbon O Predominantly Inorganic Fossil-based Kemira APRIL 25, 2023 INVESTOR PRESENTATION ~250 ~200 500 ~100 2019 2020 2021 2022 2030 target 24 24

View entire presentation